Literature DB >> 18197788

Spray-dried powders for pulmonary drug delivery.

Peter C Seville1, Hao-ying Li, Tristan P Learoyd.   

Abstract

Powders for inhalation are traditionally prepared using a destructive micronization process such as jet milling to reduce the particle size of the drug to 2-5 mum. The resultant particles are typically highly cohesive and display poor aerosolization properties, necessitating the addition of a coarse carrier particle to the micronized drug to improve powder flowability. Spray-drying technology offers an alternative, constructive particle production technique to the traditional destructive approach, which may be particularly useful when processing biotechnology products that could be adversely affected by high-energy micronization processes. Advantages of spray drying include the ability to incorporate a wide range of excipients into the spray-drying feedstock, which could modify the aerosolization and stability characterizations of the resultant powders, as well as modify the drug release and absorption profiles following inhalation. This review discusses some of the reasons why pulmonary drug delivery is becoming an increasingly popular route of administration and describes the various investigations that have been undertaken in the preparation of spray-dried powders for pulmonary drug delivery.

Mesh:

Substances:

Year:  2007        PMID: 18197788     DOI: 10.1615/critrevtherdrugcarriersyst.v24.i4.10

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  12 in total

1.  Preparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers.

Authors:  Jing-Jing Yang; Chun-Yu Liu; Li-Hui Quan; Yong-Hong Liao
Journal:  AAPS PharmSciTech       Date:  2012-05-30       Impact factor: 3.246

2.  Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.

Authors:  Changcheng Zhu; Yoko Shoji; Scott McCray; Michael Burke; Caitlin E Hartman; Jessica A Chichester; Jeff Breit; Vidadi Yusibov; Dexiang Chen; Manjari Lal
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

3.  Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling.

Authors:  Junhong Ling; Sharad Mangal; Heejun Park; Shaoning Wang; Alex Cavallaro; Qi Tony Zhou
Journal:  J Pharm Sci       Date:  2019-05-18       Impact factor: 3.534

4.  Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.

Authors:  Tobias W M Keil; Daniel P Feldmann; Gabriella Costabile; Qian Zhong; Sandro da Rocha; Olivia M Merkel
Journal:  Eur J Pharm Biopharm       Date:  2019-08-21       Impact factor: 5.571

5.  Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process.

Authors:  Pall Thor Ingvarsson; Mingshi Yang; Helle Mulvad; Hanne Mørck Nielsen; Jukka Rantanen; Camilla Foged
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

6.  Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.

Authors:  Yu Lin; Rachel Yoon Kyung Chang; Warwick J Britton; Sandra Morales; Elizabeth Kutter; Jian Li; Hak-Kim Chan
Journal:  Eur J Pharm Biopharm       Date:  2019-08-06       Impact factor: 5.571

7.  Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency.

Authors:  Chiara Parlati; Paolo Colombo; Francesca Buttini; Paul M Young; Handoko Adi; Alaina J Ammit; Daniela Traini
Journal:  Pharm Res       Date:  2009-01-31       Impact factor: 4.200

8.  Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and Rifampicin.

Authors:  Wenbo Wang; Qi Tony Zhou; Si-Ping Sun; John A Denman; Thomas R Gengenbach; Nicolas Barraud; Scott A Rice; Jian Li; Mingshi Yang; Hak-Kim Chan
Journal:  AAPS J       Date:  2015-11-24       Impact factor: 4.009

9.  An Inhalable Powder Formulation Based on Micro- and Nanoparticles Containing 5-Fluorouracil for the Treatment of Metastatic Melanoma.

Authors:  Kelly Cristine Zatta; Luiza A Frank; Luciano Antonio Reolon; Lucas Amaral-Machado; Eryvaldo S T Egito; Maria Palmira Daflon Gremião; Adriana Raffin Pohlmann; Silvia S Guterres
Journal:  Nanomaterials (Basel)       Date:  2018-01-30       Impact factor: 5.076

Review 10.  Inhalation delivery technology for genome-editing of respiratory diseases.

Authors:  Michael Y T Chow; Rachel Yoon Kyung Chang; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2020-06-05       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.